Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Prevalence estimates of use of cancer screening tests among American Indian/Alaska Native and non-Hispanic White adults resident in CHSDA counties—Behavioral Risk Factor Surveillance System, 2000–2006a

 NHW TotalaAI/AN TotalaNorthern PlainsbAlaskacSouthern PlainsdPacific CoasteEastfSouthwestg
%h(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)%(95% CI)
Mammography within 2 years, women aged 40+i
Papanicolaou (Pap) test within 3 years women without hysterectomyi
Prostate specific antigen test within 1 year, men aged 50–75j
Fecal occult blood test within 1 year or endoscopy within 5 years, aged 50+j

CHSDA indicates Contract Health Service Delivery Areas of the Indian Health Service; NHW, non-Hispanic whites; AI/AN, American Indians/Alaska Natives; 95% CI, 95% confidence interval.

a Data from 33 U.S. states (includes states listed in the footnotes below).
b AI/AN in Indiana, Iowa, Michigan, Minnesota, Montana, Nebraska, North Dakota, South Dakota, Wisconsin, and Wyoming.
c AI/AN in Alaska.
d AI/AN in Kansas, Oklahoma, and Texas.
e AI/AN in California, Idaho, Oregon, and Washington.
f AI/AN in Alabama, Connecticut, Florida, Louisiana, Maine, Massachusetts, Mississippi, New York, North Carolina, Rhode Island, and South Carolina.
g AI/AN in Arizona, Colorado, Nevada, New Mexico, and Utah.
h All prevalence estimates are weighted and age-adjusted to the 2000 US standard population. “Refused” and “don’t know” responses are excluded.
i 2000, 2002, 2004, and 2006 (AI/AN estimates do not include Massachusetts).
j 2001, 2002, 2004, and 2006 (AI/AN estimates do not include Massachusetts).

Download table formatted for print (PDF-36KB)